Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
European Heart Journal|May 19, 2015
Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humansNeil Ruparelia, Jernej Godec, Regent Lee, et al.Chemosphere|July 19, 2022
Comparative study of ozonation and ozonation catalyzed by Fe-loaded biochar as catalyst to remove methylene blue from aqueous solutionMuhammad Babar, Hafiz Muhammad Shahzad Munir, Aamna Nawaz, et al.Frontiers in Microbiology|November 14, 2024
Unleashing the synergistic effect of promising fungicides: a breakthrough solution for combating powdery mildew in pea plantsMaria, Ishrat Naz, Rizwan Khan, et al.Asian Pacific Journal of Tropical Medicine|September 6, 2017
First report on molecular characterization of Leishmania species from cutaneous leishmaniasis patients in southern Khyber Pakhtunkhwa province of PakistanMubbashir Hussain, Shahzad Munir, Sultan Ayaz, et al.Thrombosis and Haemostasis|May 27, 2019
Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled TrialSalahaddin Ubaid, Thomas J Ford, Colin Berry, et al.Frontiers in Plant Science|February 7, 2022
Defeating Huanglongbing Pathogen Candidatus Liberibacter asiaticus With Indigenous Citrus Endophyte Bacillus subtilis L1-21Shahzad Munir, Yongmei Li, Pengbo He, et al.Frontiers in Plant Science|April 15, 2022
Corrigendum: Defeating Huanglongbing Pathogen Candidatus Liberibacter asiaticus With Indigenous Citrus Endophyte Bacillus subtilis L1-21Shahzad Munir, Yongmei Li, Pengbo He, et al.Lancet (London, England)|July 9, 2014
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trialAdeel Shahzad, Ian Kemp, Christine Mars, et al.Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.European Heart Journal. Quality of Care & Clinical Outcomes|September 28, 2024
Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine Coronary Computed Tomography AngiographyApostolos Tsiachristas, Kenneth Chan, Elizabeth Wahome, et al.Pageof 10